Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
Key figures
- Market capCalculated value looks implausible
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 18
- 13F valueReported value at the end of Q2 2026
- $146.5K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $4.86M
- −3.7% year over year
- Net income, FY2025
- -$2.34M
- No comparable prior period
- Free cash flow, FY2025
- -$4.74M
- No comparable prior period
- Revenue, Q2 FY2026
- $1.44M
- −0.8% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 115.6K
- Shares sold short
- Change
- −227.3K
- −66.3% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding RKDA, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding RKDA at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Arcadia Biosciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Kawakami MarkChief Financial Officer | PPurchase | +700 | $2.49 | +$1.74K | +35.3%2.68K after | |
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Schaefer Thomas J.Chief Executive Officer | PPurchase | +700 | $2.49 | +$1.74K | +33.0%2.82K after | |
| Aug 20, 2024 (view filing) | Aug 1 | 19 daysLate | Kawakami MarkChief Financial Officer | PPurchase | +700 | $2.06 | +$1.44K | +54.6%1.98K after | |
| Aug 20, 2024 (view filing) | Aug 1 | 19 daysLate | Schaefer Thomas J.Chief Executive Officer | PPurchase | +700 | $2.06 | +$1.44K | +49.3%2.12K after | |
| Feb 5, 2024 (view filing) | Feb 1 | 4 days | Schaefer Thomas J.Chief Financial Officer | PPurchase | +700 | $2.06 | +$1.44K | +97.4%1.42K after | |
| Aug 7, 2023 (view filing) | Aug 4 | 3 days | Schaefer Thomas J.Chief Financial Officer | PPurchase | +649 | $3.67 | +$2.38K | +927.1%719 after | |
| May 30, 2023 (view filing) | May 30 | Same day | Jacot Stanley JrChief Executive Officer | PPurchase | +5.00K | $4.31 | +$21.6K | New position5.00K after | |
| Feb 2, 2023 (view filing)7:07 PM ET | Feb 1 | 1 day | Schaefer Thomas J.Chief Financial Officer | PPurchase | +700 | $0.23 | +$161 | +33.3%2.80K after | |
| Aug 3, 2022 (view filing) | Aug 1 | 2 days | Haley PamelaChief Financial Officer | PPurchase | +700 | $0.70 | +$490 | +16.0%5.09K after |
Top 10 13F holders, Q2 2026
See all 18 holdersThe largest institutional positions in Arcadia Biosciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 88,386 | $60.0K | 0.00% | +88,386 | New |
| Citadel Advisors LLC | 23,738 | $16.1K | 0.00% | +23,738 | New |
| Virtu Financial LLC | 21,786 | $15.0K | 0.00% | +21,786 | New |
| StoneX Group Inc. | 13,682 | $11.3K | 0.00% | +13,682 | New |
| Geode Capital Management, LLC | 16,135 | $11.0K | 0.00% | −15,608−49.2% | Reduced |
| XTX Topco Ltd | 15,475 | $10.5K | 0.00% | +15,475 | New |
| State Street Corp | 12,146 | $8.25K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 10,245 | $6.96K | 0.00% | +10,245 | New |
| Vanguard Capital Management LLC | 9,644 | $6.55K | 0.00% | 00.0% | Unchanged |
| Bullock Wealth Management Group | 1,000 | $749 | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of RKDA
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Arcadia Biosciences, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| MJL Manager LLC | 13G | 15.70%378.7K shares | New | Sep 30, 20261 filing | Sep 30, 2026 | SEC |
| Armistice Capital, LLC | 13G/A | 9.99%267.4K shares | +2.24 ppfrom 7.75% | Feb 14, 20234 filings | Aug 14, 2026 | SEC |